Print

Codexis Pharmaceuticals Names Fernando Valle Research Fellow  
11/4/2009 8:29:16 AM

REDWOOD CITY, Calif., Nov. 4 /PRNewswire/ -- Codexis, Inc. today announced that Fernando Valle, Ph.D., has joined the company as Codexis' first Research Fellow. Dr. Valle, a distinguished researcher in metabolic and genetic engineering over a nearly 30-year career in industrial biotechnology, will focus on Codexis' advanced biofuels programs. He will report to Lori Giver, Ph.D., Vice President, Synthetic Biology.

"Fernando Valle is one of our industry's leading experts in metabolic engineering and in developing technology for real world commercial applications," said David Anton, Ph.D., Senior Vice President, Research and Development. "While at Genencor, he played a pivotal role in developing the successful metabolic pathway leading to commercial scale production of the chemical intermediate 1,3-propanediol (PDO, used in a wide variety of industrial applications ranging from carpet to airplane deicing fluids). We are delighted to welcome him to Codexis and our research leadership team. Codexis' ability to attract world class talent like Fernando is a clear indication of our preeminent position in cellular engineering."

Contact: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771.

CONTACT: Lyn Christenson of Codexis, Inc., +1-650-421-8144,
lyn.christenson@codexis.com; or Saskia Sidenfaden, +1-212-827-3771,
ssidenfaden@mww.com, for Codexis, Inc.

Web site: http://www.codexis.com/


//-->